Given a potential tumour maintaining role of HDAC1/2 through association with p63 in squamous cell carcinoma, HDAC1 and HDAC2 might also be promising targets in skin cancer treatment (Ramsey et al, 2011). This evidence concerns the gene HDAC2 and neoplasm.